FDA Approves Symproic for OIC Approvals, Constipation, FDA, FDA/Regulatory, Opioid-Induced Constipation (OIC) The U.S. FDA approved Symproic (naldemedine) 0.2 mg tablets C-II for treating opioid-induced constipation in adult patients with chronic non-cancer pain. Read more March 23, 2017/by Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 Business Wire https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Business Wire2017-03-23 22:50:482017-03-24 13:51:03FDA Approves Symproic for OIC
